Eamonn Warren
Eli Lilly and Company
Sr. Vice President, Global Parenteral Manufacturing
Eamonn began his career with Lilly in 1995 at the Kinsale manufacturing site in Ireland. His first
role was as an automation engineer, followed by various roles in engineering, operations leadership, Six sigma and HR. He left the Kinsale site in 2007 for an international development assignment where he had assignments in Indianapolis and Puerto Rico. He subsequently held various manufacturing site head roles at the Elanco Animal Health site at Augusta, Georgia, Device Manufacturing in Indianapolis and the Fegersheim site in France.
Eamonn moved back to Indianapolis in 2021 when he took on leadership of the Global Parenteral Manufacturing Network and joined the Manufacturing Lead Team. He assumed his current role in 2024 and now has responsibility for Lilly’s global manufacturing network of internal and external sites for Active Pharmaceutical Ingredient (API) and Dry products.
A native of Ireland, he holds degrees in Chemical Engineering and Management and Marketing from University College Dublin and Cork respectively.
role was as an automation engineer, followed by various roles in engineering, operations leadership, Six sigma and HR. He left the Kinsale site in 2007 for an international development assignment where he had assignments in Indianapolis and Puerto Rico. He subsequently held various manufacturing site head roles at the Elanco Animal Health site at Augusta, Georgia, Device Manufacturing in Indianapolis and the Fegersheim site in France.
Eamonn moved back to Indianapolis in 2021 when he took on leadership of the Global Parenteral Manufacturing Network and joined the Manufacturing Lead Team. He assumed his current role in 2024 and now has responsibility for Lilly’s global manufacturing network of internal and external sites for Active Pharmaceutical Ingredient (API) and Dry products.
A native of Ireland, he holds degrees in Chemical Engineering and Management and Marketing from University College Dublin and Cork respectively.